Dataset Information


CD8+ T cell subpopulations and pro-inflammatory cytokines in neuromyelitis optica spectrum disorder.



Our study aimed to investigate circulating CD8+ T cell subpopulations and pro-inflammatory cytokines in the neuromyelitis optica spectrum disorder (NMOSD).


A total of 121 peripheral blood samples were obtained from 57 patients with NMOSD, 34 patients with multiple sclerosis (MS), and 30 sex- and age-matched healthy controls (HCs) for detection of CD8+ T cell subpopulations, including phenotypes of naïve (TN , CD62Lhi CD45RO- ), effector/memory (TE/M , CD62Llo CD45RO+ ), memory precursor (TMP , CD127hi KLRG1lo ), and short lived effector (TSLEC , CD127lo KLRG1hi ). In addition, 36 samples from 18 NMOSD, 12 MS, and 6 sex- and age-matched HCs for detecting pro-inflammatory cytokines (IFN? and TNF?) using flow cytometry.


Compared with HCs, we found significantly reduced CD8+ TN and increased CD8+ TE/M in both NMOSD and MS?while decreased CD8+ TMP was only observed in NMOSD. Patients treated with immunotherapy were associated with increased CD8+ TN and decreased CD8+ TE/M in NMOSD. Moreover NMOSD cohort showed significant higher proportions of IFN?+ CD8+ T cells and proportions of TNF?+ CD8+ T cells than HC and MS cohorts. On the contrary, obviously decreased IFN? and TNF? were found in NMOSD patients treated with immunotherapy. Furthermore, Multivariate linear regression analyses revealed that age was negatively correlated with CD8+ TN and TMP , and positively associated with TSLEC ; however, sex, EDSS scores and disease phase were not significantly associated with CD8+ T subpopulations.


This current study provides an evidence that circulating CD8+ T cell with abnormal subpopulations and increased pro-inflammatory were associated with pathogenesis of autoimmune demyelinating disease of CNS, especially in NMOSD.


PROVIDER: S-EPMC7818084 | BioStudies | 2021-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5390367 | BioStudies
2007-01-01 | S-EPMC2034442 | BioStudies
2006-01-01 | S-EPMC2118360 | BioStudies
2019-01-01 | S-EPMC6618021 | BioStudies
2018-01-01 | S-EPMC6207712 | BioStudies
2021-01-01 | S-EPMC7814460 | BioStudies
2019-01-01 | S-EPMC6593687 | BioStudies
2020-01-01 | S-EPMC7664265 | BioStudies
1000-01-01 | S-EPMC2584723 | BioStudies
2016-01-01 | S-EPMC5061747 | BioStudies